Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Kalish

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Controlled Clinical Trials|April 1, 1990
Permutation tests following restricted randomization proceduresL A Kalish
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
Relationships of body size with breast cancerL A Kalish
Biometrics|June 1, 1990
Reducing mean squared error in the analysis of pair-matched case-control studiesL A Kalish
Biometrics|September 1, 1990
Efficient design for estimation of median lethal dose and quantal dose-response curvesL A Kalish
American Journal of Epidemiology|March 1, 1986
Matching on a non-risk factor in the design of case-control studies does not always result in an efficiency lossL A Kalish
Statistics in Medicine|April 1, 1985
Treatment allocation methods in clinical trials: a reviewL A Kalish, C B Begg
Biometrics|September 1, 1988
Efficiency of balanced treatment allocation for survival analysisL A Kalish, D P Harrington
Biometrics|June 1, 1984
Treatment allocation for nonlinear models in clinical trials: the logistic modelC B Begg, L A Kalish
Controlled Clinical Trials|August 1, 1997
Number of phones for telephone randomizationL A Kalish, H A Feldman
Urology|December 22, 1999
Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSAL A Kalish, J B McKinlay
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Controlled Clinical Trials|April 1, 1990
Permutation tests following restricted randomization proceduresL A Kalish
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
Relationships of body size with breast cancerL A Kalish
Biometrics|June 1, 1990
Reducing mean squared error in the analysis of pair-matched case-control studiesL A Kalish
Biometrics|September 1, 1990
Efficient design for estimation of median lethal dose and quantal dose-response curvesL A Kalish
American Journal of Epidemiology|March 1, 1986
Matching on a non-risk factor in the design of case-control studies does not always result in an efficiency lossL A Kalish
Statistics in Medicine|April 1, 1985
Treatment allocation methods in clinical trials: a reviewL A Kalish, C B Begg
Biometrics|September 1, 1988
Efficiency of balanced treatment allocation for survival analysisL A Kalish, D P Harrington
Biometrics|June 1, 1984
Treatment allocation for nonlinear models in clinical trials: the logistic modelC B Begg, L A Kalish
Controlled Clinical Trials|August 1, 1997
Number of phones for telephone randomizationL A Kalish, H A Feldman
Urology|December 22, 1999
Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSAL A Kalish, J B McKinlay
Pageof 8